BMJ Calls for Release of Tamiflu Studies
As part of their “open data campaign,” British Medical Journal (BMJ) is asking for the release of clinical trial data related to the effectiveness of Roche’s Tamiflu. Researchers at the journal have claimed there is no evidence that Tamiflu can actually stop the flu.
Roche Has Not Released Tamiflu Data
- In 2009, BMJ researchers asked Roche to make its Tamiflu study data available to the public. According to BMJ editor Fiona Godlee, Roche failed to comply, citing “legal restraints.”
- In 2011, Tamiflu was included on a list of “essential medicines” by the World Health Organization, prompting governments across the world to stockpile the drug.
- In 2012, one BMJ researcher suggested that European governments boycott Roche's products until they publish the missing Tamiflu data.
Roche Medications Under Investigation
On October 23, 2012, the European Medicines Agency announced it was investigating reports that Roche failed to properly report side-effects and deaths related to 19 drugs, including Tamiflu. A number of the drugs were used for the treatment of cancer, including breast cancer.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/ or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of defective medications or medical devices, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.